You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

For further information on Zejula (niraparib) and potential side effects please see: Zejula 100mg Hard Capsule patient information and Zejula 100mg film-coated tablet patient information

Zejula is a registered trademark of the GlaxoSmithKline group of companies

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the product package leaflet. You can also report side effects directly to HPRA Pharmacovigilance on their website: By reporting side effects, you can help provide more information on the safety of this medicine.